Davis KL, Cote I, Kaye JA, Gao H, Perez Ronco J, Seifeldin R, Mendelson E. Real-world assessment of clinical outcomes in lower-risk myelofibrosis patients receiving treatment with ruxolitinib. Poster presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition; December 6, 2014. San Francisco, CA. [abstract] Blood. 2014 Dec 6; 124(21):1857. doi: 10.1182/blood.V124.21.1857.1857
Goyal R, Davis KL, Cote I, Mounedji N, Kaye JA. Increased incidence of thromboembolic event rates in patients diagnosed with polycythemia vera: results from an observational cohort study. Poster presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition; December 6, 2014. San Francisco, CA. [abstract] Blood. 2014 Dec 6; 124(21):4840. doi: 10.1182/blood.V124.21.4840.4840
Karve SJ, Price GL, Davis KL, Pohl GM, Smyth E, Bowman L. Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers. BMC Health Serv Res. 2014 Nov 13;14(1):555. doi: 10.1186/s12913-014-0555-8
Graham CN, Davis KL, Goyal RK. Effect of sample size and data maturity on parametric survival modeling projections in advanced cancer. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam.
Davis KL, Wei W, Meyers JL, Kilpatrick BS, Pandya N. Use of basal insulin and the associated clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus: a retrospective chart review study. Clin Interv Aging. 2014 Oct 23;2014(9):1815-22. doi: 10.2147/CIA.S65411
Davis KL, Wei W, Meyers JL, Kilpatrick BS, Pandya N. Association between different hemoglobin a1c levels and clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus. J Am Med Dir Assoc. 2014 Oct;15(10):757-962. doi: 10.1016/j.jamda.2014.06.007
Loftus EV, Davis KL, Wang CC, Dastani H, Luo A. Treatment patterns, complications, and disease relapse in a real-world population of patients with moderate-to-severe ulcerative colitis initiating immunomodulator therapy. Inflamm Bowel Dis. 2014 Aug;20(8):1361-7. doi: 10.1097/MIB.0000000000000089
Goyal RK, Able SL, Davis KL, Brown J, Li L, Kaye JA. Real-world treatment patterns for advanced squamous non-small cell lung cancer in the U.S. Medicare population. Poster presented at the 2014 ASCO Annual Meeting; May 2014. Chicago, IL. [abstract] J Clin Oncol. 2014 Jun 11; 32(suppl):e17652.
Davis KL, Kurosky SK. Recent trends in incidence of infant pertussis hospitalization in the United States. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014.
Davis KL, Kurosky SK. Recent trends in costs, length of stay, and mortality associated with infant pertussis hospitalization in the United States. Presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014.
Kurosky SK, Davis KL, Karve SJ. Tetanus toxoid, reduced diphtheria toxoid, and acellular puertussis (TDAP) vaccine compliance among adolescents in the United States, 2010-2012. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014.
Blonde L, Brunton S, Chava B, Zhou R, Davis KL, Meyers JL, Dalal M, Digenio A. Achievement of goal A1C (less than 7%) by US patients with T2DM on basal insulin in both randomized controlled trials (RCTS) and in clinical practice. Poster presented at the American Diabetes Association; June 2014. San Francisco, CA.
Ariely R, Korsnes JS, Mitra D, Davis KL, Bell C. Major adverse cardiovascular events in U.S. acute coronary syndrome patients in the United States. Poster presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions; June 2014.
Rubin DT, Mody R, Davis KL, Wang CC. Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease. Aliment Pharmacol Ther. 2014 May;39(10):1143-55. doi: 10.1111/apt.12727
Davis KL, Mody R, Patel H, Rubin DT. Association between Inadequate Response to Initial Treatment with Biologics and Health Care Costs in Patients with Inflammatory Bowel Disease. Poster presented at the 2014 AMCP 26th Annual Meeting & Expo; April 2014.
Price GL, Davis KL, Karve S, Pohl G, Walgren RA. Survival patterns in United States (US) Medicare enrollees with non-CML myeloproliferative neoplasms (MPN). PLoS One. 2014 Mar 11;9(3):e90299. doi: 10.1371/journal.pone.0090299